G. J. Braathen, Genetic epidemiology of Charcot-Marie-Tooth disease, Acta Neurol Scand, vol.126, p.22, 2012.
DOI : 10.1111/j.1468-1331.2010.03037.x

J. Berciano, A. García, and E. Gallardo, Intermediate Charcot-MarieTooth disease: an electrophysiological reappraisal and systematic review, J Neurol, vol.264, pp.1655-77, 2017.
DOI : 10.1007/s00415-017-8474-3

V. Timmerman, A. V. Strickland, and S. Züchner, Genetics of CharcotMarie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success, Genes, vol.5, pp.13-32, 2014.

C. Gonzaga-jauregui, T. Harel, and T. Gambin, Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy, Cell Rep, vol.12, pp.1169-83, 2015.
DOI : 10.1016/j.celrep.2015.07.023
URL : https://hal.archives-ouvertes.fr/hal-01958695

J. P. Desvignes, M. Bartoli, and V. Delague, VarAFT: a variant annotation and filtration system for human next generation sequencing data, Nucleic Acids Res. In Press, vol.46, pp.545-553, 2018.
DOI : 10.1093/nar/gky471
URL : https://hal.archives-ouvertes.fr/hal-01852493

J. M. Schwarz, C. Rödelsperger, and M. Schuelke, MutationTaster evaluates disease-causing potential of sequence alterations, Nat Methods, vol.7, pp.575-581, 2010.

P. Kumar, S. Henikoff, and P. C. Ng, Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm, Nat Protoc, vol.4, pp.1073-81, 2009.

I. A. Adzhubei, S. Schmidt, and L. Peshkin, A method and server for predicting damaging missense mutations, Nat Methods, vol.7, pp.248-257, 2010.
DOI : 10.1038/nmeth0410-248
URL : http://europepmc.org/articles/pmc2855889?pdf=render

D. Salgado, J. P. Desvignes, and G. Rai, UMD-Predictor: A Highthroughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution, Hum Mutat, vol.37, pp.439-485, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01670164

S. Richards, N. Aziz, and S. Bale, Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology, Genet Med, vol.17, pp.405-428, 2015.

J. M. Ellingford, C. Campbell, and S. Barton, Validation of copy number variation analysis for next-generation sequencing diagnostics, Eur J Hum Genet, vol.25, pp.719-743, 2017.
DOI : 10.1038/ejhg.2017.42
URL : https://www.nature.com/articles/ejhg201742.pdf

M. H. Wieme, M. Ben, H. Yosr, and B. , Confirmation of the spinal motor neuron gene 2 (SMN2) copy numbers by real-time PCR, Diagn Mol Pathol, vol.21, pp.172-177, 2012.

L. Vissers, K. Van-nimwegen, and J. H. Schieving, A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology, Genet Med, vol.19, pp.1055-63, 2017.

G. R. Monroe, G. W. Frederix, and S. M. Savelberg, Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability, Genet Med, vol.18, pp.949-56, 2016.

M. Tazir, T. Hamadouche, and S. Nouioua, Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update, J Neurol Sci, vol.347, pp.14-22, 2014.
DOI : 10.1016/j.jns.2014.10.013

A. S. Saporta, S. L. Sottile, and L. J. Miller, Charcot-Marie-Tooth disease subtypes and genetic testing strategies, Ann Neurol, vol.69, pp.22-33, 2011.

C. Divincenzo, C. D. Elzinga, and A. C. Medeiros, The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy, Mol Genet Genomic Med, vol.2, pp.522-531, 2014.

T. Hartley, J. D. Wagner, and J. Warman-chardon, Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: Outcomes from a cohort of 50 families, Clin Genet, vol.93, 2018.

M. F. Dohrn, N. Glöckle, and L. Mulahasanovic, Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies, J Neurochem, vol.143, pp.507-529, 2017.
DOI : 10.1111/jnc.14217
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.14217

O. Boyer, F. Nevo, and E. Plaisier, INF2 mutations in Charcot-MarieTooth disease with glomerulopathy, N Engl J Med, vol.365, pp.2377-88, 2011.
DOI : 10.1056/nejmoa1109122
URL : https://digital.csic.es/bitstream/10261/57029/1/AlonsoMA_NEJM_2377.pdf

G. Kuhlenbäumer, M. C. Hannibal, and E. Nelis, Mutations in SEPT9 cause hereditary neuralgic amyotrophy, Nat Genet, vol.37, pp.1044-1050, 2005.

K. Verhoeven, P. De-jonghe, and T. Van-de-putte, Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10, Am J Hum Genet, vol.73, pp.926-958, 2003.

E. Sinkiewicz-darol, A. F. Lacerda, and A. Kostera-pruszczyk, The LITAF/SIMPLE I92V sequence variant results in an earlier age of onset of CMT1A/HNPP diseases, Neurogenetics, vol.16, pp.27-32, 2015.

R. Pfundt, D. Rosario, M. Vissers, and L. , Detection of clinically relevant copy-number variants by exome sequencing in a large cohort of genetic disorders, Genet Med, vol.19, pp.667-75, 2017.

J. Senderek, C. Bergmann, and C. Stendel, Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy, Am J Hum Genet, vol.73, pp.1106-1125, 2003.

K. Silander, P. Meretoja, and H. Pihko, Screening for connexin 32 mutations in Charcot-Marie-Tooth disease families with possible X-linked inheritance, Hum Genet, vol.100, pp.391-398, 1997.

G. Landouré, A. A. Zdebik, and T. L. Martinez, Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C, Nat Genet, vol.42, pp.170-174, 2010.

K. Kijima, C. Numakura, and H. Izumino, Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A, Hum Genet, vol.116, pp.23-30, 2005.

G. M. Fabrizi, M. Ferrarini, and T. Cavallaro, Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease, Neurology, vol.69, pp.291-296, 2007.

S. Benedetti, S. C. Previtali, and S. Coviello, Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis, Arch Neurol, vol.67, pp.1498-505, 2010.

I. Maystadt, M. Zarhrate, and P. Landrieu, Allelic heterogeneity of SMARD1 at the IGHMBP2 locus, Hum Mutat, vol.23, pp.525-531, 2004.

V. A. Street, C. L. Bennett, and J. D. Goldy, Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C, Neurology, vol.60, pp.22-28, 2003.

E. Nelis, S. Erdem, . Van-den, and P. Y. Bergh, Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy, Neurology, vol.59, pp.1865-72, 2002.

P. Latour, C. Thauvin-robinet, and C. Baudelet-méry, A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease, Am J Hum Genet, vol.86, pp.77-82, 2010.

C. Y. Chow, Y. Zhang, and J. J. Dowling, Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J, Nature, vol.448, pp.68-72, 2007.

L. Pedrola, A. Espert, and X. Wu, GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria, Hum Mol Genet, vol.14, pp.1087-94, 2005.

R. Sivera, C. Espinós, and J. J. Vílchez, Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease, J Peripher Nerv Syst, vol.15, pp.334-378, 2010.

G. M. Fabrizi, T. Cavallaro, and C. Angiari, Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton, Brain, vol.130, pp.394-403, 2007.

T. Yoshihara, M. Yamamoto, and N. Hattori, Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals, J Peripher Nerv Syst, vol.7, pp.221-225, 2002.

R. Gooding, J. Colomer, and R. King, A novel Gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes, J Med Genet, vol.42, p.69, 2005.

K. S. Sitarz, P. Yu-wai-man, and A. Pyle, MFN2 mutations cause compensatory mitochondrial DNA proliferation, Brain, vol.135, pp.219-222, 2012.

E. Villard, C. Perret, and F. Gary, A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy, Eur Heart J, vol.32, pp.1065-76, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00616568

D. Selcen, F. Muntoni, and B. K. Burton, Mutation in BAG3 causes severe dominant childhood muscular dystrophy, Ann Neurol, vol.65, pp.83-92, 2009.

J. Hantke, D. Chandler, and R. King, A mutation in an alternative untranslated exon of hexokinase 1 associated with hereditary motor and sensory neuropathy-Russe (HMSNR), Eur J Hum Genet, vol.17, pp.1606-1620, 2009.

A. M. Rossor, G. L. Davidson, and J. Blake, A novel p.Gln175X [corrected] premature stop mutation in the C-terminal end of HSP27 is a cause of CMT2, J Peripher Nerv Syst, vol.17, pp.201-206, 2012.

B. O. Choi, M. S. Lee, and S. H. Shin, Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients, Hum Mutat, vol.24, pp.185-191, 2004.

P. Bomont, C. Ioos, and C. Yalcinkaya, Identification of seven novel mutations in the GAN gene, Hum Mutat, vol.21, p.446, 2003.

S. Suriyanarayanan, M. Auranen, and J. Toppila, The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy, Neuromolecular Med, vol.18, pp.81-90, 2016.